Current evidence of coronary artery bypass grafting off-pump versus on-pump: a systematic review with meta-analysis of over 16,900 patients investigated in randomized controlled trials†.
In the present systematic review with meta-analysis, we sought to determine the current strength of evidence for or against off-pump and on-pump coronary artery bypass grafting (CABG) with regard to hard clinical end-points, graft patency and cost-effectiveness. We performed a meta-analysis of only randomized controlled trials (RCT) which reported at least one of the desired end-points including: (i) major adverse cardiac and cerebrovascular events (MACCE), (ii) all-cause mortality, (iii) myocardial infarction, (iv) cerebrovascular accident, (v) repeat revascularization, (vi) graft patency and (vii) cost-effectiveness. The pooled treatment effects [odds ratio (OR) or weighted mean difference, 95% confidence intervals (95% CIs)] were assessed using a fixed or random effects model. A total of 16 904 patients from 51 studies were identified after literature search of the major databases using a predefined keyword list. The incidence of MACCE did not differ between the groups, neither during the first 30 days (OR: 0.93; 95% CI: 0.82-1.04) nor for the longest available follow-up (OR: 1.01; 95% CI: 0.92-1.12). While the incidence of mid-term graft failure (OR: 1.37; 95% CI: 1.09-1.72) and the need for repeat revascularization (OR: 1.55; 95% CI: 1.33-1.80) was increased after off-pump surgery, on-pump surgery was associated with an increased occurrence of stroke (OR: 0.74; 95% CI: 0.58-0.95), renal impairment (OR: 0.79; 95% CI: 0.71-0.89) and mediastinitis (OR: 0.44; 95% CI: 0.31-0.62). There was no difference with regard to hard clinical end-points between on- or off-pump surgery, including myocardial infarction or mortality. The present systematic review emphasizes that both off- and on-pump surgery provide excellent and comparable results in patients requiring surgical revascularization. The choice for either strategy should take into account the individual patient profile (comorbidities, life expectancy, etc.) and importantly, the surgeon's experience in performing on- or off-pump CABG in their routine practice.
Department of Cardiothoracic Surgery, Heart Center of the University of Cologne, Cologne, Germany antje-christin.deppe@uk-koeln.de.
Antje-Christin
AC
Deppe
Department of Cardiothoracic Surgery, Heart Center of the University of Cologne, Cologne, Germany.
Wasim
W
Arbash
Department of Cardiothoracic Surgery, Heart Center of the University of Cologne, Cologne, Germany.
Elmar W
EW
Kuhn
Department of Cardiothoracic Surgery, Heart Center of the University of Cologne, Cologne, Germany.
Ingo
I
Slottosch
Department of Cardiothoracic Surgery, Heart Center of the University of Cologne, Cologne, Germany.
Maximilian
M
Scherner
Department of Cardiothoracic Surgery, Heart Center of the University of Cologne, Cologne, Germany.
Oliver J
OJ
Liakopoulos
Department of Cardiothoracic Surgery, Heart Center of the University of Cologne, Cologne, Germany Center of Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
Yeong-Hoon
YH
Choi
Department of Cardiothoracic Surgery, Heart Center of the University of Cologne, Cologne, Germany.
Thorsten
T
Wahlers
D001026:Coronary Artery Bypass / Q000009:adverse effects / Q000379:methods / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D007902:Length of Stay; D008297:Male; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
CABG; Meta-analysis; OPCAB; Off-pump myocardial revascularization; On-pump myocardial revascularization